BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17572715)

  • 61. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities.
    Sutton L; Kuentz M; Cordonnier C; Blaise D; Devergie A; Guyotat D; Leblond V; Flesch M; Bordigoni P; Attal M
    Bone Marrow Transplant; 1993 Dec; 12(6):583-9. PubMed ID: 8136742
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.
    Hallböök H; Hägglund H; Stockelberg D; Nilsson PG; Karlsson K; Björkholm M; Linderholm M; Wahlin A; Linder O; Smedmyr B;
    Bone Marrow Transplant; 2005 Jun; 35(12):1141-8. PubMed ID: 15834433
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.
    Al-Ali H; Cross M; Lange T; Freund M; Dölken G; Niederwieser D
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S17-22. PubMed ID: 19561407
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Outcome of acute lymphoblastic leukaemia in Danish children after allogeneic bone marrow transplantation. Superior survival following transplantation with matched unrelated donor grafts.
    Lausen BF; Heilmann C; Vindeløv L; Jacobsen N
    Bone Marrow Transplant; 1998 Aug; 22(4):325-30. PubMed ID: 9722066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The outcome of allogeneic hematopoietic stem cell transplants without total body irradiation in pediatric patients with acute lymphoblastic leukemia: single centre experience.
    Hamidieh A; Kargar M; Jahani M; Alimoghaddam K; Bahar B; Mousavi SA; Iravani M; Jalali A; Jalili M; Ghavamzadeh A
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):101-7. PubMed ID: 22367385
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.
    Brochstein JA; Kernan NA; Groshen S; Cirrincione C; Shank B; Emanuel D; Laver J; O'Reilly RJ
    N Engl J Med; 1987 Dec; 317(26):1618-24. PubMed ID: 3317056
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation.
    Kim JH; Stein A; Tsai N; Schultheiss TE; Palmer J; Liu A; Rosenthal J; Forman SJ; Wong JY
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):75-81. PubMed ID: 24725691
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Utility of cranial boost in addition to total body irradiation in the treatment of high risk acute lymphoblastic leukemia.
    Alexander BM; Wechsler D; Braun TM; Levine J; Herman J; Yanik G; Hutchinson R; Pierce LJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1191-6. PubMed ID: 15978741
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia.
    Baker KS; Bostrom B; DeFor T; Ramsay NK; Woods WG; Blazar BR
    Bone Marrow Transplant; 2000 Sep; 26(6):607-14. PubMed ID: 11041565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia.
    Kim HJ; Min WS; Eom KS; Cho BS; Kim SY; Bok JN; Kim KS; Min CK; Lee S; Cho SG; Kim DW; Lee JW; Kim CC
    Bone Marrow Transplant; 2007 Dec; 40(11):1069-74. PubMed ID: 17922041
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Allogeneic bone marrow transplantation for acute leukaemia--IGCI experience. International Group for Chemo-Immunotherapy.
    Labar B; Masszi T; Morabito F; Mistrik M; Holowiecki J; Bogdanić V; Nemet D; Mrsić M; Krieger O; Lutz D
    Bone Marrow Transplant; 1996 Jun; 17(6):1009-12. PubMed ID: 8807107
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up.
    Vaidya SJ; Atra A; Bahl S; Pinkerton CR; Calvagna V; Horton C; Milan S; Shepherd V; Brain C; Treleaven J; Powles R; Tait D; Meller ST
    Bone Marrow Transplant; 2000 Mar; 25(6):599-603. PubMed ID: 10734293
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon).
    Muñoz A; Diaz-Heredia C; Diaz MA; Badell I; Verdeguer A; Martinez A; Gomez P; Perez-Hurtado JM; Bureo E; Fernandez-Delgado R; Gonzalez-Valentin ME; Maldonado MS
    Pediatr Hematol Oncol; 2008 Jun; 25(4):245-59. PubMed ID: 18484470
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants.
    Kornblit B; Masmas T; Madsen HO; Ryder LP; Svejgaard A; Jakobsen B; Sengeløv H; Olesen G; Heilmann C; Dickmeiss E; Petersen SL; Vindeløv L
    Bone Marrow Transplant; 2008 May; 41(10):851-9. PubMed ID: 18246114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.